In case 1980's Blues Brothers didn't let you know John Landis loves him some classic rhythm and blues, in 1985, John Landis hired B.B. King to do the entire soundtrack for his movie Into The Night.
It not only got us another good flick and a good soundtrack, it got us B.B. King covering pieces like this Wilson Pickett standard. And B.B. does it better. If I was Emperor For A Day, the horn section would play the instrumental bridge from 1:30 everywhere I went, and at window shattering volume, until you could feel it vibrate your skull.
Maybe someone reading here?
ReplyDeleteLooks like someone trolled antifa
'Anti-fascist' protestors in California, New York, Ohio and Pennsylvania rally against 'White Lives Matter' marches that never materialized despite KKK's advertisements
More than 100 'anti-fascist' protesters descended on Huntington Beach in California on Sunday to demonstrate against the 'White Lives Matter' rally there that never happened - just a week after residents received KKK propaganda at their homes advertising a planned march.
n
Or maybe it wasn't entirely a troll...
ReplyDeletehttps://www.zerohedge.com/political/total-chaos-unlawful-assembly-declared-huntington-beach-when-white-lives-matter-clashed
n
Aesop, you may ban for this, but there is no way in heck that B.B. King's version of "In the Midnight Hour" beats the Wicked Wilson Picket version done at Stax. I love B.B. King and have saw him live back in the 1980s - he was fabulous - but Pickett owns that tune, period. For starters, he wrote it along with Steve Cropper, and you just aren't going to find a funkier, tighter band than the band at Stax, Booker T. and the M.G.'s, et al. Since you already probably hate me, there are several other versions out there which top King's, including the one the Blues Brothers did live at some of their shows.
ReplyDeleteOver the years, I attended 14 BB King concerts. Greatest showman and blues player ever!
ReplyDeleteWilson had more soul singing it, but B.B.'s horn section leaves Pickett's in the dust.
ReplyDeleteRe: "Wilson had more soul singing it, but B.B.'s horn section leaves Pickett's in the dust."
DeleteI disagree... and would note that King's version benefited from a quarter-century's worth of technological improvement in recording and stereo tech, but suit yourself of course. King does a nice job with the tune; there's no denying that. You have heard of the Memphis Horns, right? One of the most-recorded horn sections in popular music, at least up until they finally hung it professionally. That's who played the horn charts on almost all of those old Stax-Volt recordings.
Do yourself a favor: The charts on "In the Midnight Hour" are good, but plenty of the horn arrangements on later Pickett tunes are even better. Check those out; I think you'll be glad you did. And not just the horns, either - the personnel in some of those recording sessions is legendary, to say the least. Muscle Shoals Rhythm Section, the cream of the Sound of Philly, The Dixie Flyers, American Studios, you name it... those boys were laying it down.
OT, but more detail about the J&J&j possible blood clotting issue... most of you pro's will have already received this via channels, but here it is.
ReplyDeleteCases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine
As of April 12, 2021, approximately 6.85 million doses of the Johnson & Johnson (J&J) COVID-19 vaccine (Janssen) have been administered in the United States. The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the J&J COVID-19 vaccine that were reported to the Vaccine Adverse Event Reporting System (VAERS). In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women aged 18–48 years. The interval from vaccine receipt to symptom onset ranged from 6–13 days. One patient died. Providers should maintain a high index of suspension for symptoms that might represent serious thrombotic events or thrombocytopenia in patients who have recently received the J&J COVID-19 vaccine. When these specific types of blood clots are observed following J&J COVID-19 vaccination, treatment is different from the treatment that might typically be administered for blood clots. Based on studies conducted among the patients diagnosed with immune thrombotic thrombocytopenia after the AstraZeneca COVID-19 vaccine in Europe, the pathogenesis of these rare and unusual adverse events after vaccination may be associated with platelet-activating antibodies against platelet factor-4 (PF4), a type of protein. Usually, the anticoagulant drug called heparin is used to treat blood clots. In this setting, the use of heparin may be harmful, and alternative treatments need to be given.
CDC will convene an emergency meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday, April 14, 2021, to further review these cases and assess potential implications on vaccine policy. FDA will review that analysis as it also investigates these cases. Until that process is complete, CDC and FDA are recommending a pause in the use of the J&J COVID-19 vaccine out of an abundance of caution. The purpose of this Health Alert is, in part, to ensure that the healthcare provider community is aware of the potential for these adverse events and can provide proper management due to the unique treatment required with this type of blood clot.
https://emergency.cdc.gov/han/2021/han00442.asp
n